CureDuchenne Blog

UT Southwestern Wellstone Symposium

We are excited about the UT Southwestern Wellstone Symposium on March 30!  Don’t forget to RSVP by March 1.  We’ll see you there!  [download id=”13142″ template=”UT Southwestern Wellstone Symposium “]

NS Pharma Community Letter

We are excited that our industry partner, NS Pharma, has applied for accelertated approval for it’s exon 53 skipping therapy, viltolarsen. We applaud the dedication to the Duchenne community by […]

World Muscle Society: Day 3 Highlights

Highlights from day three at the World Muscle Society meeting in Mendoza, Argentina, provided by CureDuchnne’s scientist, Dr. Mike Kelly.  Mallinckrodt Pharmaceuticals Mallinckrodt provided an update on their Phase 2 […]

World Muscle Society: Day 2 Highlights

Highlights from day two at the World Muscle Society meeting in Mendoza, Argentina, provided by CureDuchnne’s scientist, Dr. Mike Kelly. Sarepta’s Gene Therapy Program: Sarepta provided a much-anticipated update on […]

World Muscle Society Meeting: Day 1 Highlights

Highlights from the first day at the World Muscle Society meeting in Mendoza, Argentina, provided by CureDuchnne’s scientist, Dr. Mike Kelly.  Carrier-mothers: It’s recognized that Duchenne and Becker muscular dystrophy […]